DexCom and smart ring maker ŌURA today announced a strategic partnership for the integration of Dexcom glucose data with vital sign, sleep, stress, heart health and activity data from Oura Ring. Combining Dexcom glucose data with the biometrics collected by Oura Ring will provide users of both products with a more complete picture of overall health. Dexcom is also making a $75 million strategic investment in ŌURA Series D funding, with ŌURA now valued at more than $5 billion.
With this partnership, Dexcom and ŌURA will launch integrations enabling data to flow between Dexcom and ŌURA products, including Dexcom glucose biosensors, Dexcom apps, Oura Ring and the Oura App, so shared users can track their glucose levels and understand the impact of behaviors and biology on their metabolic health. The companies will also co-market and cross-sell each other’s products. The first app integration resulting from the partnership is expected to launch in the first half of 2025.
Dexcom has been specializing in glucose biosensing for 25 years. Most recently, Dexcom launched Stelo, what it called the first glucose biosensor cleared for use without a prescription in the U.S.
Earlier this year, ŌURA announced that it has sold 2.5 million rings, expects to see annual sales double in 2024 to roughly $500 million, and is profitable. ŌURA also introduced a new feature, Meals, to Oura Labs (an opt-in innovation hub within the Oura App that allows members to test features in development and provide feedback) that enables tracking meal timing and maps that timing to their chronotype to understand how, what and when we eat can impact health metrics like sleep, stress and recovery.
